In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
Abstract
Source Citation
Abstract
Clinical Impact Ratings
Get full access to this article
View all available purchase options and get full access to this article.
References
Information & Authors
Information
Published In
History
Keywords
Copyright
Authors
Author Disclosures
Metrics & Citations
Metrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
In T2DM with CKD, semaglutide reduced major kidney disease events at 3 y. Ann Intern Med.2024;177:JC98. [Epub 3 September 2024]. doi:10.7326/ANNALS-24-01579-JC
View More
Login Options:
Purchase
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.
Create your Free Account
You will be redirected to acponline.org to create an account that will provide access to Annals.
Comments
0 Comments